Prostate Cancer News

• Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone Men with metastatic disease who received enzalutamide demonstrated a small but significant survival benefit. The study was published as a preprint and has not yet been peer reviewed.
  Medscape Medical News, May 20, 2022
• AUA 2022 AUA 2022: A Report From the Trenches Colorado urologist Henry M. Rosevear, MD, offers his take on the scientific highlights of this year's annual meeting of the American Urological Association.
  Medscape Medical News, May 19, 2022
• Mastectomy May Not Be Necessary for Young Breast Cancer Patients Mastectomies among younger women with nonmetastatic invasive breast cancer may not always be necessary, suggests a study that shows survival outcomes are similar after a lumpectomy.
  Medscape Medical News, May 17, 2022
• AUA 2022 Most Men With Low-Risk Prostate Tumors Now Forgoing Treatment Acceptance of active surveillance for low-risk prostate cancer hit a record high in 2021, although the US still lags internationally, new figures showed.
  Medscape Medical News, May 15, 2022
• Nearly 234,000 Cancer Cases Predicted in Canada This Year Although overall cancer rates are declining in Canada, the number of cases and deaths continue to climb due to population growth and an aging population.
  Medscape Medical News, May 13, 2022
• AUA 2022 New Guideline Gives Active Surveillance a Boost The 2022 guidance for the first time makes active surveillance the recommended treatment for select patients with favorable intermediate-risk Gleason 3+4 prostate cancer.
  Medscape Medical News, May 10, 2022
• Novartis Suspends Two Cancer Therapies Over Quality Concerns Novartis said on Thursday it had temporarily suspended the production of its Lutathera and Pluvicto cancer therapies at facilities in Italy and New Jersey after potential quality issues were discovered in their manufacturing.
  Reuters Health Information, May 05, 2022
• Proton-Beam Therapy Increasingly Popular in the US Physicians in the US are increasingly using proton-beam therapy to treat newly diagnosed cancer patients, a new study finds.
  Reuters Health Information, May 05, 2022
• Genetic Test for Six Chronic Diseases Undergoing Clinical Trial Researchers developed assays and supportive information to examine the expanded role of genetic information in patient care.
  Medscape Medical News, April 29, 2022
• High Suicide, Depression Risks for Patients With Cancer Two comprehensive studies provide strong evidence of the psychological impact cancer diagnoses and treatment can have on patients and reveal the need to ramp up mental health services.
  Medscape Medical News, April 25, 2022
• Support for Risk-Adapted Androgen Deprivation Plus High-Dose Radiotherapy in Prostate Cancer New data support the use of high-dose external beam radiotherapy combined with risk-adapted androgen deprivation in men with unfavorable prostate cancer.
  Reuters Health Information, April 22, 2022
• Pinterest Rife With Misleading Cancer Nutrition Info Cancer-related nutrition "pins" often claim to prevent, treat, or cure cancer, with many pinners selling dubious products or services to patients and survivors.
  Medscape Medical News, April 22, 2022
• Nitrites and Nitrates Associated With Increased Cancer Risk The chemicals, which are commonly used as food additives in processed meats, are associated with increased risks for prostate cancer and breast cancer.
  Medscape Medical News, April 19, 2022
• Time to Remove 'Cancer' Label From Low-Risk Prostate Tumors? Dropping the 'C word' would curtail anxiety and reduce overtreatment, some experts have argued, but not everyone embraces the idea.
  Medscape Medical News, April 18, 2022
• AACR 2022 Genetically Adjusted PSA May Improve Prostate Cancer Screening A validated genetic score can adjust PSA values to reduce overdiagnosis of prostate cancer and help distinguish clinically significant disease from indolent cancer.
  Medscape Medical News, April 14, 2022
• AACR 2022 Better Survival in Older Cancer Patients Who Also Take Metformin Older patients with advanced cancer who also had diabetes and were taking metformin were found to have better survival than those not taking metformin.
  Medscape Medical News, April 12, 2022
• Can Cancer Blood Tests Live Up to Promise of Saving Lives? The Canby, Oregon, resident had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people.
  Associated Press, April 11, 2022
• No Survival Benefit Found in Routine Screening MRI for Spinal Cord Compression in Prostate Cancer Routine screening MRI and pre-emptive treatment for spinal cord compression in patients with asymptomatic castration-resistant prostate cancer is not justified, according to UK-based researchers.
  Reuters Health Information, April 07, 2022
• Low Use of Bone Scans/Drugs for Men on ADT for Prostate Cancer Rates of guideline-recommended bone scans were low, and rates of use of bone drugs even lower, among older men on androgen deprivation therapy (ADT) for prostate cancer.
  Medscape Medical News, April 05, 2022
• Obesity Increasing the Risk for Cancer: It's Complicated Will the public health messages about obesity and cancer have to be rewritten now that a new analysis has questioned some of the links found in older studies?
  Medscape Medical News, March 30, 2022